ADCETRIS [brentuximab vedotin]
Discussion of key data from ECHELON-2 Francine Foss, MD
13:10
ADCETRIS [brentuximab vedotin]
Value of CD30 expression as a percentage Francine Foss, MD
11:13
ADCETRIS [brentuximab vedotin]
Managing treatment with ADCETRIS®+CHP Francine Foss, MD
14:11
ADCETRIS [brentuximab vedotin]
Middle-Aged Adult Patient Case: Making Your Chance Count
19:20
ADCETRIS [brentuximab vedotin]
Young Adult Patient Case: Making Your Chance Count
19:21
ADCETRIS [brentuximab vedotin]
ECHELON-1: Moving Forward
18:58
ADCETRIS [brentuximab vedotin]
ADCETRIS® mechanism of action
12:19
ADCETRIS [brentuximab vedotin]
Indications and important safety information
9:49
ADCETRIS [brentuximab vedotin]
Justin’s treatment experience with ADCETRIS®
8:56
ADCETRIS [brentuximab vedotin]
What to expect and how to prepare for treatment with ADCETRIS®
10:16
ADCETRIS [brentuximab vedotin]
Justin’s diagnosis story | ADCETRIS®
10:36
ADCETRIS [brentuximab vedotin]
Looking ahead with ADCETRIS®: Mary Ann’s inspiring journey
10:47
ADCETRIS [brentuximab vedotin]
Mary Ann embraces data and research in considering ADCETRIS®
9:07
ADCETRIS [brentuximab vedotin]
Partnering with my oncologist: Mary Ann’s experience with ADCETRIS®
9:41
ADCETRIS [brentuximab vedotin]
How family support helped Brandon's journey
9:26
ADCETRIS [brentuximab vedotin]
Learn how Brandon chose ADCETRIS® for his treatment
9:40
ADCETRIS [brentuximab vedotin]
Brandon shares the importance of getting a second opinion
9:52
ADCETRIS [brentuximab vedotin]
Amina, ADCETRIS®, and the importance of the patient’s voice
9:42
ADCETRIS [brentuximab vedotin]
Amina talks about support when starting ADCETRIS® treatment
8:37
ADCETRIS [brentuximab vedotin]
The steps Amina took before choosing ADCETRIS®
9:23
ADCETRIS [brentuximab vedotin]
ADCETRIS® ClinCases discussion featuring Dr Andrew Whiteley
18:30
ADCETRIS [brentuximab vedotin]
Indications and important safety information for patients
6:53